ScripsAmerica Placed on 'Earnings Watch' With Positive Revenue Guidance

NEW CASTLE, Del., March 28, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that Ludlow Research, an equity research firm based in New York, has placed an 'earnings watch' on the Company, which is preparing to report its fiscal 2012 financial results.

Ludlow Research projects that while ScripsAmerica may show low to moderate growth for 2012 due to expiring and renewing contracts during that twelve-month period, the Company will post strong revenues and sales for the current quarter and remainder of 2013. The research update highlights that ScripsAmerica recorded its highest monthly revenue ever of $904,275 this January followed by $849,039 in February, a 115% increase over February 2012.

Based on its record start to the year and the Company's projections, ScripsAmerica could achieve over $10 million in revenue for fiscal 2013, representing an annual growth rate of 50% over 2011. To view the full report, and access risks, disclosures, and potential outlook visit:

Ludlow Equity Research is a New York-based equity research firm focused on providing its clients and readers with in-depth research coverage and opinions on the small-cap securities market. For over 14 years, it has provided traders with an easy way to make investment decisions based on current and future valuations. Ludlow Equity Research is a division of Ludlow Capital, Inc.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the healthcare industry through the largest pharmaceutical distributor in North America, McKesson Corporation. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, CutisPharma, Inc., MedVet and the U.S. Veterans Administration.

For more information, visit

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: ScripsAmerica, Inc. Phone: 888-959-7095 Email: Melissa Diaz, South Street Media, Inc Phone: (917) 937-8968 Email: info@southstreetmedia.comSource:ScripsAmerica, Inc.